Devicor Medical Products Group LLC, the medical device holding company that bought the breast-care business of Johnson & Johnson’s (NYSE:JNJ) Ethicon Endo-Surgery two weeks ago, drummed up $151.5 million in an equity offering.
Devicor Medical Products
Devicor Medical Products Inc. acquired the breast care unit from the Johnson & Johnson (NYSE:JNJ)subsidiary Ethicon-Endo Surgery.
The newly acquired business will be known as Mammotome, a Devicor Medical Products company. As part of the deal, Devicor also acquired marketing and distribution rights for Neoprobe Gamma Detection Systems (OTC:NEOP).
Ethicon Endo-Surgery Inc. is entertaining an offer from a private equity-backed holding company for its breast care business, including the MammoTome biopsy system.
The Johnson & Johnson (NYSE:JNJ) subsidiary has until June 15 to decide whether to accept the offer from Devicor Medical Products, a portfolio company of GTCR Golder Rauner LLC. Specific terms of the offer were not disclosed.